A recently published report describes the case of a 59-year-old male patient who experienced olmesartan-associated enteropathy (OAE) and highlights the importance of performing thorough medication reviews.
In patients with hypertension, psoriasis linked to increased risk for cardiovascular procedures, surgeries.
Patients with type 2 diabetes treated with liraglutide experience a greater reduction in systolic BP if they have lower baseline continuous glucose monitoring values and higher diastolic BP.
Members of 2 remote Venezuelan tribes were found to have elevated blood pressure following exposure to Western culture.
Lower systolic BP found for those living in areas with public smoke-free policies.
Updated cholesterol guidelines offer more personalized cardiovascular disease risk assessment.
Treatment of low-risk patients presenting with mild hypertension with antihypertensive medication should be done with caution.
Intensive blood pressure control and fenofibrate use in patients with type 2 diabetes who are at high risk for cardiovascular disease may increase the risk for adverse kidney events.
Discord among international, organizational blood pressure guidelines have led to confusion between physicians and patients alike.
Tibia lead levels are associated with resistant-hypertension.
